{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T15:08:56Z","timestamp":1793286536781,"version":"4.5.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T00:00:00Z","timestamp":1697155200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T00:00:00Z","timestamp":1697155200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002352","name":"Ain Shams University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100002352","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Aim<\/jats:title>\n                <jats:p>Although macrovascular complications represent the leading cause of mortality in type 1 diabetes mellitus (T1DM), the prevalence of subtle macrovascular affection including peripheral artery disease (PAD) among children with T1DM and its genetic predictors remains to be unraveled. Increasing evidence suggests a link between adiponectin rs1501299 and chemerin rs17173608 gene polymorphism and atherogenesis, and insulin resistance. Hence, this study assess the prevalence of these variants among children with T1DM in comparison to healthy controls and their association with macrovascular complications, namely PAD and hyperlipidemia.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Fifty children with T1DM and 50 matched controls underwent a thorough assessment including adiponectin rs1501299 and chemerin rs17173608 gene polymorphisms, fasting lipids, glycated hemoglobin (HbA1c), and ankle\u2013brachial index (ABI). Cochran\u2013Armitage trend test was used to decide the risk allele and evaluate the association between the candidate variant and PAD using a case\u2013control design.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Children with T1DM were found to have significantly higher ABI (<jats:italic>p<\/jats:italic>\u2009=\u20090.011) than controls. Chemerin gene polymorphism was detected in 41 children with T1DM (82.0%), while adiponectin gene polymorphism was detected in 19 children (38.0%). Children with T1DM having GG chemerin variant and those having TT adiponectin variant had significantly higher cholesterol with significantly lower HDL-C and ABI than those having the other two variants (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.005). Children with T1DM having abnormal ABI had significantly higher chemerin G (<jats:italic>p<\/jats:italic>\u2009=\u20090.017) and adiponectin T (<jats:italic>p<\/jats:italic>\u2009=\u20090.022) alleles than those with normal ABI. Cholesterol and ABI were independently associated with chemerin and adiponectin gene polymorphism by multivariable regression analysis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Children with T1DM having chemerin and adiponectin gene polymorphisms have significantly higher cholesterol and ABI than those without these polymorphisms and controls.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Trial registration<\/jats:title>\n                <jats:p>The Research Ethics Committee of Ain Shams University, approval number R 31\/2021.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s40618-023-02215-z","type":"journal-article","created":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T06:01:50Z","timestamp":1697176910000},"page":"983-994","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Adiponectin rs1501299 and chemerin rs17173608 gene polymorphism in children with type 1 diabetes mellitus: relation with macroangiopathy and peripheral artery disease"],"prefix":"10.1007","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6507-8835","authenticated-orcid":false,"given":"N. Y.","family":"Salah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. S.","family":"Madkour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K. S.","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. A.","family":"Abdelhakam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F. A.","family":"Abdullah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. A. E. H.","family":"Mahmoud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,10,13]]},"reference":[{"issue":"3","key":"2215_CR1","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1007\/s13300-019-0612-8","volume":"10","author":"J Schofield","year":"2019","unstructured":"Schofield J, Ho J, Soran H (2019) Cardiovascular risk in type 1 diabetes mellitus. Diabetes Ther 10(3):773\u2013789. https:\/\/doi.org\/10.1007\/s13300-019-0612-8","journal-title":"Diabetes Ther"},{"issue":"4","key":"2215_CR2","doi-asserted-by":"publisher","first-page":"798","DOI":"10.2337\/diacare.29.04.06","volume":"29","author":"S Soedamah-Muthu","year":"2006","unstructured":"Soedamah-Muthu S, Fuller J, Mulnier H, Raleigh V, Lawrenson R, Colhoun H (2006) High risk of cardiovascular disease in patients with type 1 diabetes in the U.K.: a cohort study using the general practice research database. Diabetes Care 29(4):798\u2013804. https:\/\/doi.org\/10.2337\/diacare.29.04.06. (dc05-1433)","journal-title":"Diabetes Care"},{"issue":"10","key":"2215_CR3","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1016\/S2213-8587(18)30035-4","volume":"6","author":"P Bjornstad","year":"2018","unstructured":"Bjornstad P, Donaghue KC, Maahs DM (2018) Macrovascular disease and risk factors in youth with type 1 diabetes: time to be more attentive to treatment? Lancet Diabetes Endocrinol 6(10):809\u2013820. https:\/\/doi.org\/10.1016\/S2213-8587(18)30035-4. (Epub 2018 Feb 20. Erratum in: Lancet Diabetes Endocrinol. 2018 Apr 10;: PMID: 29475800; PMCID: PMC6102087)","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"10","key":"2215_CR4","doi-asserted-by":"publisher","first-page":"2843","DOI":"10.2337\/dc14-1720","volume":"37","author":"SD de Ferranti","year":"2014","unstructured":"de Ferranti SD, de Boer IH, Fonseca V, Fox CS, Golden SH, Lavie CJ, Magge SN, Marx N, McGuire DK, Orchard TJ, Zinman B, Eckel RH (2014) Type 1 diabetes mellitus and cardiovascular disease: a scientific statement from the American Heart Association and American Diabetes Association. Diabetes Care 37(10):2843\u20132863. https:\/\/doi.org\/10.2337\/dc14-1720","journal-title":"Diabetes Care"},{"key":"2215_CR5","doi-asserted-by":"publisher","first-page":"2646","DOI":"10.2337\/dc07-0517","volume":"30","author":"RE Carter","year":"2007","unstructured":"Carter RE, Lackland DT, Cleary PA, Yim E, Lopes-Virella M, Gilbert G, Orchard T, The Diabetes Control and Complications Trial\/Epidemiology of Diabetes Interventions and Complications (DCCT\/EDIC) Study Research Group (2007) Diabetes Control and Complications Trial\/Epidemiology of Diabetes Interventions and Complications (DCCT\/EDIC) Study Research Group Intensive treatment of diabetes is associated with a reduced rate of peripheral arterial calcification in the Diabetes Control and Complications Trial. Diabetes Care 30:2646\u20132648. https:\/\/doi.org\/10.2337\/dc07-0517","journal-title":"Diabetes Care"},{"key":"2215_CR6","doi-asserted-by":"publisher","first-page":"e726","DOI":"10.1161\/CIR.0000000000000471","volume":"135","author":"MD Gerhard-Herman","year":"2017","unstructured":"Gerhard-Herman MD, Gornik HL, Barrett C, Barshes NR, Corriere MA, Drachman DE, Fleisher LA, Fowkes FG, Hamburg NM, Kinlay S, Marie D, Lookstein R, Misra S, Mureebe L, Olin J, Patel R, Regensteiner J, Schanzer A, Shishehbor M, Stewart K, Treat-Jacobson D, Walsh M (2017) AHA\/ACC guideline on the management of patients with lower extremity peripheral artery disease: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines. Circulation 135:e726\u2013e779. https:\/\/doi.org\/10.1161\/CIR.0000000000000471","journal-title":"Circulation"},{"key":"2215_CR7","doi-asserted-by":"publisher","first-page":"e171","DOI":"10.1161\/CIR.0000000000001005","volume":"144","author":"M Criqui","year":"2021","unstructured":"Criqui M, Matsushita K, Aboyans V, Hess C, Hicks C, Kwan T, McDermott M, Misra S, Ujueta F, On behalf of the American Heart Association Council on Epidemiology and Prevention; Council on Arteriosclerosis, Thrombosis and Vascular Biology; Council on Cardiovascular Radiology and Intervention; Council on Lifestyle and Cardiometabolic Health; Council on Peripheral Vascular Disease; and Stroke Council (2021) Lower extremity peripheral artery disease: contemporary epidemiology, management gaps, and future directions: a scientific statement from the American Heart Association. Circulation 144:e171\u2013e191. https:\/\/doi.org\/10.1161\/CIR.0000000000001005","journal-title":"Circulation"},{"key":"2215_CR8","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.cytogfr.2019.06.002","volume":"48","author":"W Liang","year":"2019","unstructured":"Liang W, Ye D (2019) The potential of adipokines as biomarkers and therapeutic agents for vascular complications in type 2 diabetes mellitus. Cytokine Growth Factor Rev 48:32\u201339. https:\/\/doi.org\/10.1016\/j.cytogfr.2019.06.002","journal-title":"Cytokine Growth Factor Rev"},{"key":"2215_CR9","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.1161\/STROKEAHA.110.602375","volume":"42","author":"S Bevan","year":"2011","unstructured":"Bevan S, Meidtner K, Lorenz M, Sitzer M, Grant P, Markus H (2011) Adiponectin level as a consequence of genetic variation, but not leptin level or leptin adiponectin ratio, is a risk factor for carotid intima-media thickness. Stroke 42:1510\u20131514. https:\/\/doi.org\/10.1161\/STROKEAHA.110.602375","journal-title":"Stroke"},{"key":"2215_CR10","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.1161\/ATVBAHA.118.311219","volume":"38","author":"S Zylla","year":"2018","unstructured":"Zylla S, D\u00f6rr M, V\u00f6lzke H, Schminke U, Felix S, Nauck M, Friedrich N (2018) Association of circulating chemerin with subclinical parameters of atherosclerosis. Results of a population-based study. Arteriosclerosis Thrombosis Vascular Biol 38:1656\u20131664. https:\/\/doi.org\/10.1161\/ATVBAHA.118.311219","journal-title":"Arteriosclerosis Thrombosis Vascular Biol"},{"key":"2215_CR11","doi-asserted-by":"publisher","first-page":"308","DOI":"10.2337\/dc08-1458","volume":"32","author":"P Welsh","year":"2009","unstructured":"Welsh P, Murray HM, Buckley BM, de Craen AJ, Ford I, Jukema JW, Macfarlane PW, Packard CJ, Stott DJ, Westendorp RG, Shepherd J, Sattar N (2009) Leptin predicts diabetes but not cardiovascular disease: results from a large prospective study in an elderly population. Diabetes Care 32:308\u2013310","journal-title":"Diabetes Care"},{"key":"2215_CR12","doi-asserted-by":"publisher","first-page":"375","DOI":"10.2337\/diabetes.55.02.06.db05-0747","volume":"55","author":"IM Heid","year":"2006","unstructured":"Heid IM, Wagner SA, Gohlke H, Iglseder B, Mueller JC, Cip P, Ladurner G, Reiter R, Stadlmayr A, Mackevics V, Illig T, Kronenberg F, Paulweber B (2006) Genetic architecture of the APM1 gene and its influence on adiponectin plasma levels and parameters of the metabolic syndrome in 1727 healthy Caucasians. Diabetes 55:375\u2013384","journal-title":"Diabetes"},{"key":"2215_CR13","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1093\/eurheartj\/ehm526","volume":"29","author":"S Patel","year":"2008","unstructured":"Patel S, Flyvbjerg A, Kozakova M, Frystyk J, Ibrahim IM, Petrie JR, Avery PJ, Ferrannini E, Walker M, RISC Investigators (2008) Variation in the ADIPOQ gene promoter is associated with carotid artery intima media thickness independent of plasma adiponectin levels in healthy subjects. Eur Heart J 29:386\u2013393","journal-title":"Eur Heart J"},{"key":"2215_CR14","doi-asserted-by":"publisher","first-page":"4670521","DOI":"10.1155\/2018\/4670521","volume":"2018","author":"LK Er","year":"2018","unstructured":"Er LK, Wu S, Hsu LA, Teng MS, Sun YC, Ko YL (2018) Pleiotropic associations of RARRES2 gene variants and circulating chemerin levels: potential roles of chemerin involved in the metabolic and inflammation-related diseases. Mediators Inflamm 2018:4670521. https:\/\/doi.org\/10.1155\/2018\/4670521","journal-title":"Mediators Inflamm"},{"key":"2215_CR15","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1161\/HYPERTENSIONAHA.115.05616","volume":"66","author":"KB Neves","year":"2015","unstructured":"Neves KB, Dinh Cat AN, Lopes RA, Rios FJ, Anagnostopoulou A, Lobato NS, de Oliveira AM, Tostes RC, Montezano AC, Touyz RM (2015) Chemerin regulates crosstalk between adipocytes and vascular cells through Nox. Hypertension 66:657\u2013666. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.115.05616","journal-title":"Hypertension"},{"key":"2215_CR16","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1186\/s12933-014-0145-4","volume":"13","author":"Q Ji","year":"2014","unstructured":"Ji Q, Lin Y, Liang Z, Yu K, Liu Y, Fang Z, Liu L, Shi Y, Zeng Q, Chang C, Chai M, Zhou Y (2014) Chemerin is a novel biomarker of acute coronary syndrome but not of stable angina pectoris. Cardiovasc Diabetol 13:145. https:\/\/doi.org\/10.1186\/s12933-014-0145-4","journal-title":"Cardiovasc Diabetol"},{"key":"2215_CR17","doi-asserted-by":"publisher","first-page":"59","DOI":"10.5551\/jat.9647","volume":"19","author":"HJ Yoo","year":"2012","unstructured":"Yoo HJ, Choi HY, Yang SJ, Kim HY, Seo JA, Kim SG, Kim NH, Choi KM, Choi DS, Baik SH (2012) Circulating chemerin level is independently correlated with arterial stiffness. J Atheroscler Thromb 19:59\u201366 (discussion 67)","journal-title":"J Atheroscler Thromb"},{"key":"2215_CR18","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1016\/j.metabol.2014.02.013","volume":"63","author":"KN Aronis","year":"2014","unstructured":"Aronis KN, Sahin-Efe A, Chamberland JP, Spiro A, Vokonas P, Mantzoros CS (2014) Chemerin levels as predictor of acute coronary events: a case-control study nested within the veterans\u2019 affairs normative aging study. Metabolism 63:760\u2013766. https:\/\/doi.org\/10.1016\/j.metabol.2014.02.013","journal-title":"Metabolism"},{"key":"2215_CR19","first-page":"749","volume":"16","author":"K Aydin","year":"2016","unstructured":"Aydin K, Canpolat U, Akin S, Dural M, Karakaya J, Aytemir K, Ozer N, Gurlek A (2016) Chemerin is not associated with subclinical atherosclerosis markers in prediabetes and diabetes. Anatol J Cardiol 16:749\u2013755","journal-title":"Anatol J Cardiol"},{"key":"2215_CR20","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1111\/pedi.12773","volume":"19","author":"E Mayer-Davis","year":"2018","unstructured":"Mayer-Davis E, Kahkoska A, Jefferies C, Dabelea D, Balde N, Gong C, Craig M (2018) ISPAD Clinical Practice Consensus Guidelines 2018: Definition, epidemiology, and classification of diabetes in children and adolescents. Pediatr Diabetes 19:7\u201319","journal-title":"Pediatr Diabetes"},{"issue":"8","key":"2215_CR21","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.3390\/nu11081752","volume":"11","author":"S Couch","year":"2019","unstructured":"Couch S, Urbina E, Crandell J, Liese A, Dabelea D, Kim G, Mayer-Davis E (2019) Body mass index z-score modifies the association between added sugar intake and arterial stiffness in youth with type 1 diabetes: the search nutrition ancillary study. Nutrients 11(8):1752","journal-title":"Nutrients"},{"issue":"3","key":"2215_CR22","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2017-1904","volume":"140","author":"J Flynn","year":"2017","unstructured":"Flynn J, Kaelber D, Baker-Smith C, Blowey D, Carroll A, Daniels S, de Ferranti S, Dionne J, Falkner B, Flinn S, Gidding S, Goodwin C, Leu M, Powers M, Rea C, Samuels J, Simasek M, Thaker V, Urbina E (2017) Clinical practice guideline for screening and management of high blood pressure in children and adolescents. Pediatrics 140(3):e20171904. https:\/\/doi.org\/10.1542\/peds.2017-1904","journal-title":"Pediatrics"},{"issue":"1","key":"2215_CR23","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1093\/nar\/29.1.308","volume":"29","author":"ST Sherry","year":"2001","unstructured":"Sherry ST, Ward MH, Kholodov M, Baker J, Phan L, Smigielski EM, Sirotkin K (2001) dbSNP: the NCBI database of genetic variation. Nucleic Acids Res 29(1):308\u2013311","journal-title":"Nucleic Acids Res"},{"key":"2215_CR24","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1097\/00041444-200209000-00003","volume":"12","author":"F FMcGuigan","year":"2002","unstructured":"FMcGuigan F, Ralston S (2002) Single nucleotide polymorphism detection: allelic discrimination using TaqMan. Psychiatr Genet 12:133\u2013136","journal-title":"Psychiatr Genet"},{"key":"2215_CR25","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1517\/14656566.9.5.669","volume":"9","author":"C Harley","year":"2008","unstructured":"Harley C, Gandhi S, Blasetto J, Heien H, Sasane R, Nelson SP (2008) Lipid levels and low-density lipoprotein cholesterol goal attainment in diabetic patients: rosuvastatin compared with other statins in usual care. Expert Opin Pharmacother 9:669\u2013676","journal-title":"Expert Opin Pharmacother"},{"issue":"10","key":"2215_CR26","first-page":"B64","volume":"32","author":"D Goldstein","year":"1986","unstructured":"Goldstein D, Little R, Wie-dmeyer H, England J, McKenzie E (1986) Glycated hemoglobin: methodologies and clinical applications. Clin Chem 32(10):B64-70","journal-title":"Clin Chem"},{"key":"2215_CR27","doi-asserted-by":"publisher","first-page":"2890","DOI":"10.1161\/CIR.0b013e318276fbcb","volume":"126","author":"V Aboyans","year":"2012","unstructured":"Aboyans V, Criqui MH, Abraham P, Allison M, Creager M, Diehm C, Fowkes F, Hiatt W, J\u00f6nsson B, Lacroix P, Marin B, McDermott M, Norgren L, Pande R, Preux P, Stoffers H, Treat-Jacobson D, American Heart Association Council on Peripheral Vascular Disease; Council on Epidemiology and Prevention; Council on Clinical Cardiology; Council on Cardiovascular Nursing; Council on Cardiovascular Radiology and Intervention, and Council on Cardiovascular Surgery and Anesthesia (2012) Measurement and interpretation of the ankle\u2013brachial index: a scientific statement from the American Heart Association. Circulation 126:2890\u20132909. https:\/\/doi.org\/10.1161\/CIR.0b013e318276fbcb","journal-title":"Circulation"},{"key":"2215_CR28","doi-asserted-by":"publisher","first-page":"3150","DOI":"10.1002\/sim.2250","volume":"25","author":"G Zheng","year":"2006","unstructured":"Zheng G, Gastwirth J (2006) On estimation of the variance in Cochran-Armitage trend tests for genetic association using case-control studies. Stat Med 25:3150\u20133159","journal-title":"Stat Med"},{"issue":"2","key":"2215_CR29","doi-asserted-by":"publisher","DOI":"10.1002\/dmrr.3088","volume":"35","author":"L Nattero-Ch\u00e1vez","year":"2019","unstructured":"Nattero-Ch\u00e1vez L, Redondo L\u00f3pez S, Alonso D\u00edaz S, Garnica Ure\u00f1a M, Fern\u00e1ndez-Dur\u00e1n E, Escobar-Morreale HF, Luque-Ram\u00edrez M (2019) The peripheral atherosclerotic profile in patients with type 1 diabetes warrants a thorough vascular assessment of asymptomatic patients. Diabetes Metab Res Rev 35(2):e3088","journal-title":"Diabetes Metab Res Rev"},{"issue":"1","key":"2215_CR30","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/s12933-022-01568-8","volume":"21","author":"LF Ferreira-Divino","year":"2022","unstructured":"Ferreira-Divino LF, Suvitaival T, Rotbain Curovic V, Tofte N, Tro\u0161t K, Mattila IM, Theilade S, Winther SA, Hansen TW, Frimodt-M\u00f8ller M, Legido-Quigley C, Rossing P (2022) Circulating metabolites and molecular lipid species are associated with future cardiovascular morbidity and mortality in type 1 diabetes. Cardiovasc Diabetol 21(1):135. https:\/\/doi.org\/10.1186\/s12933-022-01568-8","journal-title":"Cardiovasc Diabetol"},{"issue":"2","key":"2215_CR31","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/j.atherosclerosis.2006.03.038","volume":"191","author":"L Brewer","year":"2007","unstructured":"Brewer L, Chai H, Bailey K, Kullo I (2007) Measures of arterial stiffness and wave reflection are associated with walking distance in patients with peripheral arterial disease. Atherosclerosis 191(2):384\u2013390","journal-title":"Atherosclerosis"},{"issue":"7","key":"2215_CR32","doi-asserted-by":"publisher","first-page":"2675","DOI":"10.1210\/jc.2018-02729","volume":"104","author":"L Nattero-Ch\u00e1vez","year":"2019","unstructured":"Nattero-Ch\u00e1vez L, L\u00f3pez S, D\u00edaz S, Ure\u00f1a M, Fern\u00e1ndez-Dur\u00e1n E, Escobar-Morreale H, Luque-Ram\u00edrez M (2019) Association of cardiovascular autonomic dysfunction with peripheral arterial stiffness in patients with type 1 diabetes. J Clin Endocrinol Metab 104(7):2675\u20132684. https:\/\/doi.org\/10.1210\/jc.2018-02729","journal-title":"J Clin Endocrinol Metab"},{"key":"2215_CR33","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1253\/circj.71.377","volume":"71","author":"J Li","year":"2007","unstructured":"Li J, Luo Y, Xu Y, Yang J, Zheng L, Hasimu B, Yu J, Hu D (2007) Risk factors of peripheral arterial disease and relationship between low ABI and mortality from all-cause and cardiovascular disease in Chinese patients with type 2 diabetes. Circ J 71:377\u2013381","journal-title":"Circ J"},{"key":"2215_CR34","doi-asserted-by":"publisher","first-page":"4928","DOI":"10.3390\/ijms21144928","volume":"21","author":"I Pastore","year":"2020","unstructured":"Pastore I, Bolla A, Montefusco L, Lunati M, Rossi A, Assi E, Zuccotti G, Fiorina P (2020) The impact of diabetes mellitus on cardiovascular risk onset in children and adolescents. Int J Mol Sci 21:4928. https:\/\/doi.org\/10.3390\/ijms21144928","journal-title":"Int J Mol Sci"},{"issue":"6","key":"2215_CR35","doi-asserted-by":"publisher","first-page":"623","DOI":"10.3390\/healthcare9060623","volume":"9","author":"S Perumalsamy","year":"2021","unstructured":"Perumalsamy S, Ahmad W, Huri H (2021) Single nucleotide polymorphism rs17173608 in the chemerin encoding gene: is it a predictor of insulin resistance and severity of coronary artery disease in non-obese type 2 diabetes? Healthcare 9(6):623. https:\/\/doi.org\/10.3390\/healthcare9060623","journal-title":"Healthcare"},{"issue":"3","key":"2215_CR36","first-page":"1","volume":"15","author":"A Abdelhamid","year":"2019","unstructured":"Abdelhamid A, Zaafan M (2019) Association of Chemerin rs17173608 and Vaspin rs2236242 polymorphisms with type two diabetes mellitus and its impact on their corresponding serum levels in Egyptian population. Biomed J Sci Tech Res 15(3):1\u20136","journal-title":"Biomed J Sci Tech Res"},{"issue":"8","key":"2215_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2021.e07851","volume":"7","author":"M Howlader","year":"2021","unstructured":"Howlader M, Sultana M, Akter F, Hossain M (2021) Adiponectin gene polymorphisms associated with diabetes mellitus: a descriptive review. Heliyon 7(8):e07851. https:\/\/doi.org\/10.1016\/j.heliyon.2021.e07851","journal-title":"Heliyon"},{"key":"2215_CR38","doi-asserted-by":"publisher","first-page":"6383906","DOI":"10.1155\/2020\/6383906","volume":"2020","author":"M Cui","year":"2020","unstructured":"Cui M, Gao Y, Zhao Y, Pang H, Chen L, Wang Z, Zhao L, Li M (2020) Association between Adiponectin gene polymorphism and environmental risk factors of Type 2 diabetes mellitus among the Chinese population in Hohhot. Biomed Res Int 2020:6383906. https:\/\/doi.org\/10.1155\/2020\/6383906","journal-title":"Biomed Res Int"},{"key":"2215_CR39","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s43042-020-00063-7","volume":"21","author":"M Dahpy","year":"2020","unstructured":"Dahpy M, Khairallah M, Azoz N, Ezzat G (2020) The associations among RARRES2 rs17173608 gene polymorphism, serum chemerin, and non-traditional lipid profile in patients with metabolic syndrome. Egypt J Med Hum Genet 21:21. https:\/\/doi.org\/10.1186\/s43042-020-00063-7","journal-title":"Egypt J Med Hum Genet"},{"key":"2215_CR40","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1111\/j.1365-2265.2011.04217.x","volume":"77","author":"HY Shin","year":"2012","unstructured":"Shin HY, Lee DC, Chu SH, Jeon J, Lee M, Im J, Lee J (2012) Chemerin levels are positively correlated with abdominal visceral fat accumulation. Clin Endocrinol 77:47\u201350","journal-title":"Clin Endocrinol"},{"issue":"1","key":"2215_CR41","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.metabol.2011.06.021","volume":"61","author":"K Tsuzaki","year":"2012","unstructured":"Tsuzaki K, Kotani K, Sano Y, Fujiwara S, Gazi I, Elisaf M, Sakane N (2012) The relationship between adiponectin, an adiponectin gene polymorphism, and high-density lipoprotein particle size: from the Mima study. Metab Clin Exp 61(1):17\u201321","journal-title":"Metab Clin Exp"},{"issue":"10","key":"2215_CR42","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.116.004421","volume":"5","author":"AJ Kennedy","year":"2016","unstructured":"Kennedy AJ, Yang P, Read C, Kuc RE, Yang L, Taylor EJ, Taylor CW, Maguire JJ, Davenport AP (2016) Chemerin elicits potent constrictor actions via chemokine-like receptor 1 (CMKLR1), not G-protein-coupled receptor 1 (GPR1), in human and rat vasculature. J Am Heart Assoc 5(10):e004421. https:\/\/doi.org\/10.1161\/JAHA.116.004421","journal-title":"J Am Heart Assoc"},{"key":"2215_CR43","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/j.yjmcc.2011.09.008","volume":"52","author":"M Ding","year":"2012","unstructured":"Ding M, Carr\u00e3o AC, Wagner RJ, Xie Y, Jin Y, Rzucidlo EM, Yu J, Li W, Tellides G, Hwa J, Aprahamian TR, Martin KA (2012) Vascular smooth muscle cell-derived adiponectin: a paracrine regulator of contractile phenotype. J Mol Cell Cardiol 52:474\u2013484","journal-title":"J Mol Cell Cardiol"},{"key":"2215_CR44","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1016\/j.metabol.2006.03.008","volume":"55","author":"T Araki","year":"2006","unstructured":"Araki T, Emoto M, Teramura M, Yokoyama H, Mori K, Hatsuda S, Maeno T, Shinohara K, Koyama H, Shoji T, Inaba M, Nishizawa Y (2006) Effect of adiponectin on carotid arterial stiffness in type 2 diabetic patients treated with pioglitazone and metformin. Metabolism 55:996\u20131001","journal-title":"Metabolism"},{"key":"2215_CR45","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1161\/01.ATV.0000099786.99623.EF","volume":"24","author":"Y Matsuzawa","year":"2004","unstructured":"Matsuzawa Y, Funahashi T, Kihara S, Shimomura I (2004) Adiponectin and metabolic syndrome. Arterioscler Thromb Vasc Biol 24:29\u201333","journal-title":"Arterioscler Thromb Vasc Biol"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-023-02215-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40618-023-02215-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-023-02215-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,27]],"date-time":"2024-03-27T01:19:41Z","timestamp":1711502381000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40618-023-02215-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,13]]},"references-count":45,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2024,4]]}},"alternative-id":["2215"],"URL":"https:\/\/doi.org\/10.1007\/s40618-023-02215-z","relation":{},"ISSN":["1720-8386"],"issn-type":[{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,13]]},"assertion":[{"value":"21 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 September 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors declare no competing conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This research was approved by the Research Ethics Committee of Ain Shams University with an approval number of R 31\/2021.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Written informed consent was taken from the legal guardians of all participants.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}